The global Europe IV hydration therapy market is estimated to be valued at US$ 261.68 Mn or in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
IV hydration therapy, also known as intravenous therapy, involves delivering fluids, medications, nutrients, and blood products directly into the vein. It is commonly used for rehydration to treat dehydration, electrolyte imbalances, and hangovers. Hydration IV therapy uses customized intravenous fluids to replace nutrients and electrolytes when oral replenishment is insufficient. Various IV fluids formulations are available depending on condition to be treated which includes normal saline, isotonic fluids, dextrose saline, and electrolyte replacement fluids. Rising awareness about the advantages of IV hydration therapy for immediate replenishment is driving the market growth.
Market key trends:
Growing urbanization and increasingly sedentary lifestyle in Europe is leading to rise in health issues like dehydration. This has increased the demand for quick and effective hydration methods like IV therapy. Additionally, increasing ageing population who are more prone to dehydration is also boosting the market growth. Rapid adoption of self-administered IV hydration therapy is another key trend witnessed in the market. Unlike traditional methods, self-administered IV therapies allow patients to receive treatment in the comfort of their own home. Focus on development of organic, whole food-based IV fluids is gaining popularity. These are viewed as safer alternatives to traditional IV therapies.
Threat of new entrants: The threat of new entrants is low as iv hydration therapy market requires high initial investments and certifications.
Bargaining power of buyers: The bargaining power of buyers is moderate as buyers have various therapy options to choose from.
Bargaining power of suppliers: The bargaining power of suppliers is low as raw material suppliers face less threat due to established supply chains.
Threat of new substitutes: The threat of new substitutes is low as iv hydration therapy provides a unique healthcare solution compared to oral rehydration.
Competitive rivalry: The competitive rivalry is high among existing players to gain major market share.
The global Europe Iv Hydration Therapy Market Share is expected to witness high growth, exhibiting CAGR of 7.2% over the forecast period, due to increasing health consciousness and preference for quick rehydration therapy.
Regional analysis: Regionally, the Europe iv hydration therapy market is expected to dominate during the forecast period due to growing awareness about wellness therapies. The UK region is expected to grow at a highest CAGR of 8% owing to rise in number of iv therapy centers in major cities.
Key players: Key players operating in the Europe Iv Hydration Therapy Market are REVITA, Ivtherapygreece, IV Boost UK, Harpal Clinic Limited, IV Drips London, VITAMIN INJECTIONS LONDON, Cryojuvenate UK Ltd., Italy Health Retreats, SÃ©choir, ELIXIR, Swiss Medical Centre, Drip Hydration, REVIV, VITANOVAS, and The IV Doc Inc.